From data to impact: How real-world evidence will transform healthcare

As real-world evidence (RWE) becomes increasingly integral to healthcare decision-making, challenges around data quality, scientific rigor, and regulatory readiness continue to limit its full potential. Despite progress in RWE infrastructure and accessibility, questions remain about ensuring trust, transparency, and meaningful integration into healthcare systems globally.

In an article published in Pharmaphorum, Natalie Schibell (VP, Market Strategy and Communications) examines the accelerating role of RWE in 2025, including the importance of early investment in rigorous methodologies, global regulatory alignment, and privacy-first data strategies that ensure RWE is both credible and impactful.

Explore the full article on Pharmaphorum here.